Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
222 EUR | +2.78% | +6.73% | -1.51% |
07/05 | Transcript : Equifax Inc. Presents at Barclays Americas Select Franchise Conference 2024, May-07-2024 09:45 AM | |
06/05 | Equifax Announces Executive Changes | CI |
Strengths
- The company's profit outlook over the next few years is a strong asset.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The company returns high margins, thereby supporting business profitability.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- With an expected P/E ratio at 42.59 and 31.07 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last few months, analysts have been revising downwards their earnings forecast.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Professional Information Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-1.51% | 29.86B | - | ||
-2.03% | 135B | A- | ||
+18.45% | 75.67B | B- | ||
-14.23% | 38.44B | B+ | ||
+14.18% | 37.71B | B+ | ||
-7.94% | 16.74B | B+ | ||
+13.52% | 15.15B | C+ | ||
+11.42% | 10.5B | B | ||
-10.60% | 4.63B | B | ||
-32.51% | 4.18B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- EFX Stock
- EFX Stock
- Ratings Equifax Inc.